| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/04/2009 | CN101379087A Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling |
| 03/04/2009 | CN101379086A Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders |
| 03/04/2009 | CN101379085A IL-12/P40 binding proteins |
| 03/04/2009 | CN101379084A Novel anticoagulant polypeptides and complex |
| 03/04/2009 | CN101378782A Protein formulations with reduced viscosity and uses thereof |
| 03/04/2009 | CN101376677A Monoclonal antibody IE5 for detecting new castle disease virus variation strain |
| 03/03/2009 | US7498421 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome |
| 03/03/2009 | US7498420 Human monoclonal antibody for use in the diagnosis prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics |
| 03/03/2009 | US7498419 Crystals and structure of domain III of West Nile Virus envelope protein in association with a Fab fragment of a neutralizing antibody |
| 03/03/2009 | US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 03/03/2009 | US7498416 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 03/03/2009 | US7498415 Culturing, gene expression, transformation; fab and fv fragments; biodrugs; anticarcinogenic agents, diabetes, acromegaly |
| 03/03/2009 | US7498414 Comprising complementarity determining regions; recombinant host cells; fab fragments, fv fragments, diabodies, triabodies, and single domain antibodies; angiogenesis inhibitors; antitumor, antiproliferative, and anticarcinogenic agents; gene expression |
| 03/03/2009 | US7498407 Vascular endothelial cell growth inhibitor, VEGI-192a |
| 03/03/2009 | US7498332 Therapy for cerebral vasospasm |
| 03/03/2009 | US7498306 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/03/2009 | US7498304 Angiogenesis-modulating compositions and uses |
| 03/03/2009 | US7498298 Monomethylvaline compounds capable of conjugation to ligands |
| 03/03/2009 | US7498162 A gene expressed polypeptide is used in food, for treating food allergy |
| 03/03/2009 | US7498154 Nucleotide sequences coding cytokine receptor for identifying modulators for prevention and treatment of infection, cell proliferative and autoimmune disorders |
| 03/03/2009 | US7498143 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 03/03/2009 | US7498138 Multimerization of HIV-1 Vif protein as a therapeutic target |
| 03/03/2009 | US7498129 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
| 03/03/2009 | US7498037 Expression vector comprising nucleotide sequences coding malarial proteins for use as tool in generating vaccines against plasmodial infection; immunotherapy; antimalarial agents |
| 03/03/2009 | US7498034 Imaging, diagnosis and treatment of disease |
| 03/03/2009 | US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies |
| 03/03/2009 | US7498031 Treating sensorineural hearing loss or a vestibular disorder by administering an a PM-1antibody or an MR16-1 antibody; Meniere's disease, drug-induced inner ear disorders, viral inner ear disorders, purulent inner ear disorders, temporal bone fracture or acoustic nerve tumor |
| 03/03/2009 | US7498030 Treatment with anti-ErbB2 antibodies and anti-hormonal compounds |
| 03/03/2009 | US7498029 Photoimmunotherapies for cancer using combination therapies |
| 03/03/2009 | US7498024 Expression vector comprising nucleotide sequences coding foot and mouth viral, as well as, immunoglobulin sequences for use in generation imunotherapeutics |
| 03/03/2009 | CA2276108C Novel peptide, novel dna, and novel antibody |
| 03/03/2009 | CA2259126C Manipulation of cellulose and/or .beta.-1,4-glucan |
| 03/03/2009 | CA2238278C Antigenic protein originating in malassezia |
| 02/26/2009 | WO2009026558A1 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 02/26/2009 | WO2009026303A1 Human c-fms antigen binding proteins |
| 02/26/2009 | WO2009026155A2 Antimicrobial activity of bovine bactericidal/permeability-increasing protein (bpi) - derived peptides against gram-negative bacterial mastitis isolates |
| 02/26/2009 | WO2009026117A2 Novel compounds |
| 02/26/2009 | WO2009025867A2 Compositions of humanized notch fusion proteins and methods of treatment |
| 02/26/2009 | WO2009025401A1 Nesfatin-1 specific antibody and the use thereof, and nesfatin specific antibody and the use thereof |
| 02/26/2009 | WO2009025196A1 Foxm1 peptide and medicinal agent comprising the same |
| 02/26/2009 | WO2009025149A1 Adnf receptor |
| 02/26/2009 | WO2009025117A1 Cdca1 peptide and pharmaceutical agent comprising the same |
| 02/26/2009 | WO2009025116A1 Cdh3 peptide and medicinal agent comprising the same |
| 02/26/2009 | WO2009025080A1 Colorectal cancer marker polypeptide, and method for diagnosis of colorectal cancer |
| 02/26/2009 | WO2009024789A1 Hiv-2 antigenic peptides |
| 02/26/2009 | WO2009024653A1 Anti-idiotypic antibodies which neutralise the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii |
| 02/26/2009 | WO2009024567A1 Production method |
| 02/26/2009 | WO2009024531A1 Method for treating and diagnosing hematologic malignancies |
| 02/26/2009 | WO2009024445A1 Antibodies against human cytomegalovirus (hcmv) |
| 02/26/2009 | WO2009023961A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 02/26/2009 | WO2009023959A1 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 02/26/2009 | WO2009023955A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 02/26/2009 | WO2009002562A3 Complexes of il-15 and il-15ralpha and uses thereof |
| 02/26/2009 | WO2008157379A3 Covalent diabodies and uses thereof |
| 02/26/2009 | WO2008156833A3 G2a receptor as a therapeutic target |
| 02/26/2009 | WO2008153692A3 Microrna expression profiling of cerebrospinal fluid |
| 02/26/2009 | WO2008147143A3 Immunoglobulin fusion proteins |
| 02/26/2009 | WO2008141285A9 Methods for early diagnosis of kidney disease |
| 02/26/2009 | WO2008140580A3 Specific antibody selection by selective elution conditions |
| 02/26/2009 | WO2008136848A3 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease |
| 02/26/2009 | WO2008136736A3 Immunoregulatory structures from normally occurring proteins |
| 02/26/2009 | WO2008127711A3 Interferons of rhesus and cynomolgus origin and uses thereof |
| 02/26/2009 | WO2008110914A3 Methods for producing active scfv antibodies and libraries therefor |
| 02/26/2009 | WO2008085878A3 High affinity antibodies that neutralize staphylcoccus enterotoxin b |
| 02/26/2009 | WO2007146401A3 Denatured collagen peptides and uses thereof |
| 02/26/2009 | WO2007075979A3 In vitro germinal centers |
| 02/26/2009 | WO2006084050A9 Libraries and methods for isolating antibodies |
| 02/26/2009 | WO2005116260A3 Influenza hemagglutinin and neuraminidase variants |
| 02/26/2009 | US20090055944 Human monoclonal antibodies to be programmed death ligand 1 (pd-l1) |
| 02/26/2009 | US20090054631 Compositions and methods for treatment of non-hodgkin's lymphoma |
| 02/26/2009 | US20090054630 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 02/26/2009 | US20090054624 useful in the treatment of a condition which is responsive to the PRO polypeptide, an agonist or antagonist thereof or an anti-PRO antibody |
| 02/26/2009 | US20090054367 Mycobacterial antigens expressed under low oxygen tension |
| 02/26/2009 | US20090054361 Pot1 alternative splicing variants |
| 02/26/2009 | US20090054344 Anti-angiogenic proteins and fragments and methods of use thereof |
| 02/26/2009 | US20090054342 Bioactive peptides and method of using same |
| 02/26/2009 | US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT |
| 02/26/2009 | US20090054321 Polypeptides and use thereof |
| 02/26/2009 | US20090054300 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders |
| 02/26/2009 | US20090053831 Tyrosine phosphorylation sites |
| 02/26/2009 | US20090053826 Electropolymerisable monomers that are soluble in aqueous solution and electroactive probes that can be obtained with such monomers |
| 02/26/2009 | US20090053763 Tumor endothelial marker 7-alpha molecules and uses thereof |
| 02/26/2009 | US20090053748 Cytochrome c protein and assay |
| 02/26/2009 | US20090053739 Heme Binding Protein (HBP); use in drug screening agents that modulate FPRL2 (Formyl peptide receptor-like 2 ) |
| 02/26/2009 | US20090053737 Monoclonal Antibody Which Binds Met In Formalin-Fixed and Paraffin-Embedded Tissues and Related Methods |
| 02/26/2009 | US20090053734 Identifying antagonists agents that inhibit the function of AM, factor H, or the AM/factor H complex; cancer, diabetes; isolating AM-binding proteins wherein AM is conjugated with a label or marker and incubated with cellular or extracellular lysates |
| 02/26/2009 | US20090053730 Chimeric human t1r1 taste receptor polypeptides and compositions containing same |
| 02/26/2009 | US20090053723 Peripherin and Neurofilament Light Protein Splice Variants in Amyotrophic Lateral Sclerosis (ALS) |
| 02/26/2009 | US20090053701 Detectable nucleic acid tag |
| 02/26/2009 | US20090053300 Monoclonal antibody, gene encoding the antibody, hybridoma, pharmaceutical composition, and diagnostic reagent |
| 02/26/2009 | US20090053294 Anti Mineralocorticoid Therapy of Infection |
| 02/26/2009 | US20090053292 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 02/26/2009 | US20090053265 Antigenic peptides and their use |
| 02/26/2009 | US20090053257 Replikin peptides and uses thereof |
| 02/26/2009 | US20090053252 Bimer or an oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 02/26/2009 | US20090053248 Compositions and methods for transepithelial molecular transport |
| 02/26/2009 | US20090053247 Biological materials and uses thereof |
| 02/26/2009 | US20090053246 Immunoglobulin fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same |
| 02/26/2009 | US20090053243 Anti-IgSF4 Antibody and Utilization of the Same |
| 02/26/2009 | US20090053241 inhibition of platelet derived growth factor receptor-beta (PDGFR beta ) on angiogenesis, and provides for treatment of angiogenesis; |